| Packaging Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 296-297
|
Sterile Basics of Compounding: Repackaging, Part 1
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 298-303
|
Testosterone 2-mg and Dehydroepiandrosterone (DHEA) 15-mg Troches
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 65
|
Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 305-313
|
Comparison of Three Reconstitution Devices: A Simulated Time and Use Study
Penoyer Daleen, Giuliano Karen, Middleton Aurea
|
Mar/Apr 2023
Pg. 169-174
|
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 491-496
|
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2
Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
|
Sep/Oct 2021
Pg. 389-395
|
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 11: Particulate Issues --- Silicone Oil in Vials, Cartridges, and Syringes
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 403-408
|
A Permanent Path for Urgent-use Compounding? APC-supported Legislation Would Allow 503As to Fill Gaps in Coverage When 503Bs Cannot
Brunner Scott
|
Jul/Aug 2021
Pg. 296-297
|
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1
Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
|
Jul/Aug 2021
Pg. 298-302
|
Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 311-317
|
Stability of Dexmedetomidine in Polyvinyl Chloride Bags Containing 0.9% Sodium Chloride Intended for Subcutaneous Infusions
Wolfe Amanda, Zhang Jeremy, Lapenskie Julie, Downar James, Kanji Salmaan
|
Jul/Aug 2021
Pg. 330-335
|
Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 42
|
Evaluation of the Efficacy and Superiority of Different Vial Rubber Closure Disinfection Techniques
Bjornstad Matthew, Kosinski Tracy, Burlage Robert
|
Sep/Oct 2020
Pg. 434-438
|
Quality Control: Photostability of Compounded Preparations
Allen Loyd V Jr
|
May/Jun 2020
Pg. 200-205
|
Comparative Stability Study of Unit-dose Vancomycin Hydrochloride Oral Solutions in Plastic Capped Oral Syringes and Plastic Sealed Dosage Cups
Brown Stacy, Lewis Paul
|
May/Jun 2020
Pg. 234-237
|
Physicochemical Stability of Ternary Mixtures of Sufentanil, Baclofen, and Ropivacaine in Polypropylene Syringes for Intrathecal Analgesia
Sorrieul Jérémy, Robert Julien, Chapel Fanny, Gossye Thomas, Devys Catherine
|
Mar/Apr 2020
Pg. 156-162
|
How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems
Vaughn Stacey R, Radwick Allison
|
Jan/Feb 2020
Pg. 14-19
|
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 44-50
|
Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit
Lardinois Benjamin, Dimitriou Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence M
|
Jan/Feb 2020
Pg. 64-68
|
How to Qualify Container Closure Systems for Intended Use, Part 1
Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page
|
Nov/Dec 2019
Pg. 454-461
|
Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags
Breukels Oscar, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam
|
Jul/Aug 2018
Pg. 345-349
|
Child-safety Containers/Devices and Compounding
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 364-370
|
Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes
Kirkham Kylian, Munson Jessica M, McCluskey Susan V, Graner Kevin K
|
Sep/Oct 2017
Pg. 426-429
|
Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags
Marquis Kathleen, Hohlfelder Benjamin, Szumita Paul M
|
Sep/Oct 2017
Pg. 436-439
|
Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes
McHenry Adam R, Wempe Michael F, Rice Peter J
|
May/Jun 2017
Pg. 251-254
|
Accuracy Considerations in Sterile Compounding
Akers Michael J
|
Mar/Apr 2017
Pg. 133-142
|
Basics of Compounding: Clinical Pharmaceutics, Part 2
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 485-493
|
Stability of Fentanyl Citrate in Polyolefin Bags
Donnelly Ronald F
|
Nov/Dec 2016
Pg. 514-516
|
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 399-404
|
Long-term Stability of Vancomycin Hydrochloride in Glucose 5% Polyolefin Bags: The Brand Name Versus a Generic Product
Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
|
Sep/Oct 2016
Pg. 416-420
|
Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light
Anderson Collin R, Collins Deborah, Laursen Trevor, Arave Trevor, Helm Michael
|
Sep/Oct 2016
Pg. 435-437
|
Current Perspectives on the Syringe Delivery System
Akers Michael J
|
May/Jun 2016
Pg. 182-186
|
Topical Metered-dosing Dispenser Performance Evaluation
Liu Qiang, Kupiec Thomas C, Vu Nicole T
|
May/Jun 2016
Pg. 239-246
|
Formulation and Stability of Solutions
Akers Michael J
|
Jan/Feb 2016
Pg. 41-45
|
Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems
Akers Michael J
|
Nov/Dec 2015
Pg. 491-500
|
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers
Bhattacharya Sisir, Parekh Satish, Dedhiya Mahendra
|
Sep/Oct 2015
Pg. 432-436
|
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2
Allen Loyd V
|
Jul/Aug 2015
Pg. 280-287
|
Basics of Compounding: Compounding with Silicones
Allen Loyd V Jr
|
May/Jun 2015
Pg. 223-230
|
Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles
Dewulf Joseph, Hecq Jean-Daniel, Huvelle Sophie, Godet Marie, Gillet Patricia, Jamart Jacques, Galanti Laurence M
|
May/Jun 2015
Pg. 268-270
|
Basics of Sterile Compounding: Aseptic Processing
Akers Michael J
|
Jan/Feb 2015
Pg. 49-56
|
Stability Assessment of Repackaged Bevacizumab for Intravitreal Administration
Pereboom Marieke, Becker Matthijs L, Amenchar Mostapha, Verweij Sjoerd L, van der Hoeven Ruud TM, Mulder Inge J
|
Jan/Feb 2015
Pg. 70-72
|
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Blankenship Cynthia E
|
Sep/Oct 2014
Pg. 379-380
|
Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety
Johnson Kain, Sully Andrew, Anthenat Bruce
|
Jul/Aug 2014
Pg. 270-276
|
Basics of Compounding Sterile Preparations: Nomenclature and Considerations
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 313-317
|
Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 318-319
|
A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards
Marks Zach
|
Mar/Apr 2014
Pg. 94-99
|
Long-term Stability of Morphine Hydrochloride in 0.9% NaCl Infusion Polyolefin Bags After Freeze-thaw Treatment and in Polypropylene Syringes at 5°C ± 3°C
Hecq J-D, Godet M, Gillet P, Jamart J, Galanti L
|
Jan/Feb 2014
Pg. 78-82
|
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles
McPherson Timothy B, Neumann William L, Kolling William M
|
Nov/Dec 2013
Pg. 508-511
|
Stability of Nitroglyercin 100 mcg/mL Stored in Polypropylene Syringes
McCluskey Susan V, Vu Nicole, Rueter John
|
Nov/Dec 2013
Pg. 515-519
|
Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations
Allen Loyd V Jr
|
May/Jun 2013
Pg. 210-219
|
Basics of Compounding: Repackaging, Part 2
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 136-140
|
Basics of Compounding: Repackaging, Part 1
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 54-60
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 4: Cleaning and Packaging
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 405-414
|
Stability of Omeprazole in SyrSpend SF Alka (Reconstituted)
Whaley Paul A, Voudrie Mark A II, Sorenson Bridget
|
Mar/Apr 2012
Pg. 164-166
|
Chemical Stability of Pentoxifylline in a Topical Cream
Gupta Vishnu D
|
Jan/Feb 2012
Pg. 80-81
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 3
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 488-496
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 2
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 408-414
|
Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate
Hergert Lisandro Y, Sperandeo Norma R, Allemandi Daniel A, Mazzieri Maria R
|
Jul/Aug 2011
Pg. 344-349
|
Stability of Droperidol 0.625 mg/mL Diluted with 0.9% Sodium Chloride Injection and Stored in Polypropylene Syringes
McCluskey Susan V, Lovely Jenna K
|
Mar/Apr 2011
Pg. 170-173
|
Unit Dose Packaging and Repackaging of Solid and Liquid Dosage Forms in an Institutional Setting
McElhiney Linda F
|
Jan/Feb 2010
Pg. 32-38
|
Drug Compatibility with a New Generation of VISIV Polyolefin Infusion Solution Containers
Aloumanis Vasileios, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
|
Mar/Apr 2009
Pg. 162-165
|
Stability of Low-Concentration Ceftazidime in 0.9% Sodium Chloride Injection and Balanced Salt Solutions in Plastic Syringes Under Various Storage Conditions
Xu Meng, Warren Flynn W, Bartlett Michael G
|
Mar/Apr 2009
Pg. 166-169
|
Compendial Activities Relating to Cold Chain Management Issues: Drug Products and Compounded Preparations
Okeke Claudia C
|
Mar/Apr 2009
Pg. 128-136
|
Beyond-Use Dating, Labeling, Delivery, and Storage of Compounded and Repackaged Mediations in a Hospital or Institutional Setting
McElhiney Linda F
|
Jul/Aug 2008
Pg. 316-320
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797>
Allen Loyd V Jr, Okeke Claudia C
|
Mar/Apr 2008
Pg. 136-144
|
Standard Operating Procedure: Vial Crimper--Use, Care, Cleaning, and Maintenance
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 502-503
|
Standard Operating Procedure: Shipping of Prescriptions
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 56-57
|
Chemical Stability of Fentanyl in Polypropylene Syringes and Polyvinylchloride Bags
Donnelly Ronald F
|
Nov/Dec 2005
Pg. 482-483
|
Packaging Choices for Compounded Materials
Ambrosio Thomas J
|
Jan/Feb 2003
Pg. 37-41
|
Compounding Containment Devices: Buyer Be Aware
Kastango Eric S
|
Sep/Oct 2001
Pg. 384-388
|
Mailing and Shipping Medication: Challenges and Solutions
Gever Marcy Portnoff
|
Jul/Aug 1998
Pg. 288-292
|
Paper-Folding Techniques for Compounded, Individualized Powder Dosage Forms
Alexander Kenneth S, Li Chongua
|
Sep/Oct 1997
Pg. 340-342
|
Drug Products and Drug Packaging for the Elderly
Allen Loyd V Jr
|
May/Jun 1997
Pg. 150-151
|
| Return to Top |
